AstraZeneca’s breast cancer pill fails in a late-stage trial
Shares dip as analysts call the trial outcome a ‘manageable setback’ for investors
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.sowetanlive.co.za — the content belongs to Sowetan.